Granulocyte colony-stimulating factor: effective in ameliorating fluorouracil-based myelosuppression?
Christman
K
K
Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, NY 10021.
Saltz
L
L
Schwartz
G
G
Friedrich
C
C
Kelsen
D
D
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects*; D001853:Bone Marrow / Q000187:drug effects*; D004317:Doxorubicin / Q000009:adverse effects; D005472:Fluorouracil / Q000009:adverse effects*; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects; D009504:Neutrophils / Q000187:drug effects
D016179:Granulocyte Colony-Stimulating Factor; D004317:Doxorubicin; D005472:Fluorouracil; D008727:Methotrexate